mother
milk
deliv
natur
breastfeed
sole
sourc
infant
nutrit
mammalian
speci
million
year
sinc
human
be
learn
domest
cattl
year
ago
nonhuman
mammalian
milk
also
use
supplement
replac
matern
milk
human
infant
develop
widespread
use
commerci
prepar
infant
formula
product
phenomena
centuri
notabl
past
decad
product
provid
altern
breastfeed
use
certain
situat
nonetheless
compel
evid
show
breastfeed
ideal
sourc
infant
nutrit
whose
use
associ
lower
rate
postneonat
infant
mortal
unit
state
part
world
human
milk
help
protect
infant
wide
varieti
infect
help
reduc
risk
allerg
autoimmun
diseas
risk
obes
complic
risk
certain
type
neoplasm
later
life
associ
slightli
better
perform
test
cognit
develop
studi
reason
american
academi
pediatr
aap
world
health
organ
recommend
absenc
specif
contraind
see
benefit
risk
human
milk
healthi
term
infant
exclus
breastf
fed
express
breast
milk
begin
within
first
hour
birth
month
age
past
decad
immun
respons
intestin
respiratori
mucos
surfac
local
infect
intens
studi
investig
led
develop
concept
immun
mucos
surfac
gastrointestin
respiratori
genitourinari
tract
identif
mucosaassoci
lymphoid
tissu
local
mechan
defens
distinct
intern
system
immun
system
chapter
review
exist
inform
major
aspect
physiolog
nutrit
immunolog
antiinfect
compon
product
lactat
evid
contribut
human
milk
develop
immunolog
integr
infant
influenc
outcom
infect
hostantigen
interact
also
discuss
rudimentari
mammari
tissu
undergo
sever
development
chang
morphogenesi
lactogenesi
human
embryo
breast
tissu
appear
tini
mammari
band
chest
wall
embryon
stage
mammari
band
develop
mammari
line
along
eventu
develop
true
mammari
anlag
stage
primit
epitheli
nodul
develop
stage
primit
mammari
bud
appear
initi
phase
develop
occur
gender
tabl
develop
male
appar
limit
howev
androgen
maleassoci
substanc
castrat
male
rat
embryo
earli
gestat
lead
femal
breast
develop
wherea
ovariectomi
femal
rat
embryo
alter
cours
develop
mammari
anlag
toward
end
pregnanc
initi
phase
fetal
mammari
differenti
seem
occur
influenc
placent
transplacent
acquir
matern
hormon
transient
develop
excretori
lactifer
ductular
system
growth
differenti
secretori
activ
transient
regress
soon
birth
thelarch
later
menarch
true
mammari
growth
develop
begin
associ
rapidli
increas
level
estrogen
progesteron
growth
hormon
insulin
adrenocorticosteroid
prolactin
estrogen
seem
import
growth
develop
ductular
system
progestin
appar
import
lobuloalveolar
develop
see
tabl
final
differenti
breast
associ
growth
prolifer
acinar
lobe
alveoli
continu
influenc
level
estrogen
progesteron
peptid
hormon
prolactin
insulin
placent
chorion
somatomammotropin
appear
far
import
subsequ
induct
mainten
lactat
see
tabl
prolactin
secret
pituitari
gland
seem
neural
control
increas
innerv
breast
observ
throughout
pregnanc
appar
regul
estrogen
intens
neural
input
virgin
parturi
current
pregnant
mammal
shown
result
lactat
lactat
goat
induc
milk
maneuv
adopt
breastfeed
also
well
document
primit
human
societi
sudden
perman
cessat
suckl
result
termin
milk
secret
involut
breast
prepregn
state
concentr
prolactin
declin
estrogen
progesteron
also
may
amplifi
direct
effect
prolactin
may
induc
addit
receptor
peptid
hormon
appropri
target
tissu
breast
breast
tissu
respons
hormon
even
rudimentari
structur
illustr
secret
witch
milk
male
femal
newborn
respons
exposur
matern
secret
placent
lactogen
estrogen
progesteron
secret
earli
milk
ceas
exposur
matern
hormon
wane
sexual
differenti
mark
puberti
next
major
stage
mammari
develop
point
earlier
androgen
inhibit
develop
mammari
tissu
male
wherea
develop
mammari
tissu
femal
depend
estrogen
progesteron
pituitari
hormon
postpubert
mammari
gland
undergo
cyclic
chang
respons
releas
hormon
occur
menstrual
cycl
last
stage
develop
occur
menopaus
declin
estrogen
secret
result
atrophi
mammari
tissu
menstrual
cycl
mammari
gland
respond
sequenti
releas
estrogen
progesteron
hyperplasia
ductal
system
continu
secretori
phase
declin
onset
menstruat
concentr
prolactin
modestli
increas
follicular
stage
menstrual
cycl
remain
constant
secretori
phase
prolactin
secret
seem
held
readi
induct
mainten
lactat
pregnanc
mark
profound
hormon
chang
reflect
major
secretori
contribut
placenta
hypothalamu
pituitari
gland
contribut
mani
endocrin
gland
eg
pancrea
thyroid
parathyroid
increas
estrogen
progesteron
level
pregnanc
stimul
secret
prolactin
pituitari
wherea
placent
lactogen
seem
inhibit
releas
prolactininhibit
factor
hypothalamu
prolactin
lactogen
estrogen
progesteron
aid
prepar
mammari
gland
lactat
initi
gestat
increas
growth
ductul
alveolobular
tissu
occur
respons
estrogen
progesteron
begin
second
trimest
secretori
materi
begin
appear
lumin
cell
middl
second
trimest
mammari
develop
proceed
suffici
permit
lactat
occur
parturit
take
place
infant
deliv
major
regulatori
factor
placenta
lost
new
regulatori
factor
includ
maternalinf
interact
neuroendocrin
regul
gain
control
lactat
loss
placent
hormon
secret
result
endocrin
hypothalam
stimul
prolactin
releas
anterior
pituitari
gland
neural
stimul
oxytocin
posterior
pituitari
stimul
nippl
suckl
activ
neural
pathway
result
releas
prolactin
oxytocin
prolactin
respons
stimul
milk
product
wherea
oxytocin
stimul
milk
eject
combin
known
letdown
reflex
oxytocin
also
stimul
uterin
contract
mother
may
feel
breastfeed
respons
help
restor
uteru
prepregn
tone
milk
product
eject
depend
complex
interact
stimul
infant
suckl
neural
reflex
hypothalamu
stimul
releas
hormon
anterior
posterior
pituitari
respons
mammari
gland
hormon
complet
cycl
milk
produc
result
synthet
mechan
within
mammari
gland
transport
compon
blood
milkspecif
protein
synthes
mammari
secretori
cell
packag
secretori
vesicl
exocytos
alveolar
lumen
lactos
secret
milk
similar
manner
wherea
mani
monoval
ion
sodium
potassium
chlorid
depend
activ
transport
system
base
sodiumpotassium
adenosin
triphosphatas
na
k
atpas
situat
mammari
epithelium
may
behav
mammari
barrier
interstiti
fluid
deriv
blood
milk
lack
space
cell
may
leak
permit
direct
diffus
compon
milk
barrier
result
format
differ
pool
compart
milk
compon
within
mammari
gland
respons
maintain
gradient
compon
blood
milk
lipid
droplet
observ
within
secretori
cell
mammari
gland
surround
milk
fat
globul
membran
fat
droplet
seem
fuse
apic
membran
secretori
cell
exocytos
pinch
milk
whole
cell
also
found
milk
includ
leukocyt
macrophag
lymphocyt
broken
shed
mammari
epitheli
cell
mechan
cell
enter
milk
complex
includ
among
other
specif
cellular
receptormedi
home
antigenspecif
lymphocyt
structur
mammari
gland
compartment
structur
milk
gross
composit
milk
consist
cytoplasm
encas
cellular
membran
milk
fat
globul
membran
fat
compart
compos
fat
droplet
solubl
compart
contain
watersolubl
constitu
caseinmicel
compart
contain
acidprecipit
protein
calcium
lactos
cellular
compart
rel
amount
compon
chang
cours
lactat
gener
less
fat
protein
earli
lactat
late
lactat
infant
consum
dynam
complex
solut
physic
properti
permit
uniqu
separ
differ
function
constitu
one
anoth
presum
form
best
support
growth
develop
success
lactat
perform
depend
continu
effect
contribut
neural
endocrin
maternalinf
interact
initi
time
deliveri
part
complex
behavior
liabl
inhibit
motherchild
interact
earli
frequent
attach
infant
breast
mandatori
stimul
neural
pathway
essenti
maintain
prolactin
oxytocin
releas
healthi
newborn
infant
place
mother
breast
locat
nippl
begin
suck
spontan
within
first
hour
birth
rapid
attach
mother
may
reflect
olfactori
stimuli
breast
receiv
infant
birth
frequent
feed
necessari
mother
maintain
appropri
level
milk
product
infant
proper
growth
develop
program
support
lactat
perform
must
emphas
proper
maternalinf
bond
relax
mother
support
mother
technic
assist
initi
breastfeed
properli
cope
problem
reduct
environment
hindranc
hindranc
may
includ
lack
roomingin
hospit
use
supplement
formula
feed
lack
conveni
day
care
work
mother
lactat
ceas
suckl
stop
behavior
reduc
amount
suckl
infant
initi
wean
end
lactat
introduct
water
bottl
one
two
bottl
formula
day
may
begin
wean
process
regardless
time
parturit
damag
process
motherinf
dyad
first
establish
lactat
colostrum
milk
contain
rich
divers
nutrient
includ
electrolyt
vitamin
miner
trace
metal
nitrogen
product
enzym
immunolog
specif
cellular
solubl
product
distribut
rel
content
variou
nutrit
substanc
found
human
milk
present
tabl
chemic
composit
often
exhibit
consider
variat
among
lactat
women
woman
differ
time
lactat
sampl
obtain
mother
infant
low
birth
weight
mother
fullterm
infant
matur
milk
contain
follow
averag
amount
major
chemic
constitu
per
decilit
total
solid
g
fat
g
protein
g
whey
protein
nitrogen
mg
casein
nitrogen
mg
alactalbumin
mg
serum
albumin
mg
lactos
g
lactoferrin
mg
lysozym
mg
human
milk
contain
rel
low
amount
vitamin
e
see
tabl
littl
blactoglobulin
major
whey
protein
bovin
milk
fat
globul
membran
seem
high
content
oleic
acid
linol
acid
phosphatidylpeptid
inositol
addit
bind
ligand
promot
absorpt
zinc
identifi
human
milk
tempor
studi
indic
concentr
mani
chemic
compon
especi
nitrogen
calcium
sodium
decreas
significantli
durat
lactat
increas
sever
compon
found
chang
concentr
function
water
content
howev
total
daili
output
seem
remark
constant
least
first
week
lactat
milk
product
progress
three
distinct
phase
character
secret
colostrum
transit
earli
milk
matur
milk
colostrum
compris
lactat
product
detect
first
day
lactat
consist
yellowish
thick
fluid
mean
energi
valu
greater
kcaldl
contain
high
concentr
immunoglobulin
protein
fat
fatsolubl
vitamin
ash
transit
milk
usual
produc
day
lactat
matur
milk
produc
thereaft
concentr
mani
nutrit
compon
declin
milk
product
progress
synthesi
matur
milk
content
fatsolubl
vitamin
protein
decreas
water
content
milk
increas
convers
level
lactos
fat
watersolubl
vitamin
total
calor
content
shown
increas
lactat
matur
result
sever
manufactur
error
nutrient
composit
infant
formula
legisl
result
paradox
situat
human
milk
may
alway
meet
recommend
standard
nutrient
wherea
infant
formula
may
exceed
recommend
human
milk
nutrient
composit
vari
time
lactat
colostrum
versu
earli
milk
versu
matur
milk
extent
matern
nutrit
statu
appropri
amount
nutrient
must
consid
within
constraint
miner
content
human
milk
low
rel
infant
formula
low
compar
cow
milk
formula
prepar
although
human
milk
suffici
support
growth
develop
also
repres
fairli
low
solut
load
develop
kidney
level
major
miner
tend
declin
lactat
except
magnesium
consider
variabl
among
women
test
sodium
potassium
chlorid
calcium
zinc
phosphoru
seem
bioavail
human
milk
infant
formula
reflect
lower
concentr
human
milk
iron
readili
bioavail
infant
human
milk
may
supplement
later
lactat
preterm
infant
fed
human
milk
may
need
supplement
calcium
sodium
human
milk
contain
suffici
vitamin
maintain
infant
growth
develop
caveat
watersolubl
vitamin
particularli
depend
matern
intak
nutrient
preterm
infant
may
requir
supplement
vitamin
e
k
fed
human
milk
low
content
vitamin
human
milk
relat
develop
ricket
breastf
infant
discuss
later
aap
current
recommend
breastf
infant
receiv
iu
oral
vitamin
drop
daili
begin
first
month
life
continu
adequ
amount
vitamin
provid
daili
consumpt
infant
fortifi
formula
milk
lactos
primari
sugar
found
human
milk
usual
carbohydr
chosen
prepar
commerci
formula
lactos
suppli
approxim
half
energi
total
kcaldl
taken
infant
human
milk
lactos
disaccharid
glucos
galactos
also
may
import
neonat
carrier
galactos
may
readili
incorpor
gangliosid
central
nervou
system
galactos
deriv
glucos
neonat
also
glycogen
may
synthes
effici
galactos
glucos
neonat
rel
low
activ
glucokinas
earli
develop
human
milk
also
contain
sugar
includ
glucos
galactos
differ
oligosaccharid
oligosaccharid
may
protect
function
infant
especi
respect
abil
bind
gastrointestin
pathogen
fat
provid
almost
half
calori
human
milk
primarili
form
triacylglycerol
triglycerid
lipid
suppli
form
fat
globul
enclos
plasma
membran
deriv
mammari
epitheli
cell
essenti
fatti
acid
linol
acid
suppli
calori
deriv
lipid
fraction
triacylglycerol
serv
precursor
prostaglandin
steroid
phospholipid
carrier
fatsolubl
vitamin
lipid
profil
human
milk
differ
dramat
lipid
profil
commerci
formula
despit
consider
adapt
formula
human
milk
lipid
absorb
effici
infant
cholesterol
import
lipid
constitu
human
milk
mgdl
usual
found
trace
amount
commerci
formula
suggest
cholesterol
may
essenti
nutrient
neonat
lack
cholesterol
earli
develop
may
result
turn
cholesterolsynthet
mechan
difficult
turn
later
life
influenc
induct
hypercholesterolemia
studi
suggest
breastfeed
neonat
associ
lower
adult
serum
cholesterol
level
reduc
death
ischem
heart
diseas
interest
increas
role
longchain
polyunsatur
fatti
acid
may
play
human
milk
especi
docosahexaeno
acid
arachidon
acid
longchain
polyunsatur
fatti
acid
found
unsuppl
infant
formula
present
human
milk
structur
compon
brain
retin
membran
may
import
cognit
visual
develop
addit
may
role
prevent
atopi
numer
studi
found
infant
fed
formula
without
docosahexaeno
acid
arachidon
acid
reduc
red
blood
cell
amount
fatti
acid
howev
find
visual
cognit
function
studi
term
infant
inconsist
studi
complic
find
slower
growth
preterm
infant
fed
formula
supplement
longchain
polyunsatur
fatti
acid
inconsist
find
infant
fed
supplement
formula
may
reflect
difficulti
determin
optim
amount
docosahexaeno
acid
arachidon
acid
precursor
linol
linolen
acid
supplement
formula
lipid
seem
best
deliv
human
milk
exact
protein
content
matur
human
milk
variabl
around
gdl
contrast
infant
formula
usual
contain
gdl
milk
mother
deliv
preterm
infant
may
slightli
protein
nutrit
avail
protein
may
less
gdlpossibl
gdla
result
proport
protein
use
nonnutrit
purpos
addit
human
milk
contain
consider
greater
percentag
nonprotein
nitrogen
total
nitrogen
compar
formula
total
nitrogen
human
milk
protein
primarili
whey
predomin
acidsolubl
protein
wherea
formula
prepar
bovin
milk
classic
reflect
casein
protein
composit
speci
wheytocasein
protein
ratio
human
may
chang
lactat
whey
compon
rang
earli
milk
matur
milk
late
milk
formula
preterm
infant
reconstitut
bovin
milk
provid
whey
casein
protein
major
formula
term
infant
unit
state
bovin
wheyproteinpredomin
prepar
attempt
make
closer
human
milk
composit
differ
protein
qualiti
reflect
differ
plasma
urin
amino
acid
respons
infant
fed
human
milk
formula
caseinproteinpredomin
wheyproteinpredomin
gener
term
infant
respond
dramat
differ
seen
preterm
infant
fed
formula
differ
protein
qualiti
nonprotein
nitrogen
compon
human
milk
contain
variou
compound
may
import
develop
neonat
polyamin
nucleotid
creatinin
urea
free
amino
acid
carnitin
taurin
signific
presenc
compon
alway
clear
fed
case
infant
formula
contain
littl
taurin
soy
formula
contain
littl
carnitin
appar
defici
may
influenc
develop
infant
occur
taurin
import
bile
salt
conjug
support
appropri
develop
brain
retina
wherea
carnitin
seem
import
appropri
fatti
acid
metabol
nucleotid
particular
seem
bridg
gap
nutrit
immunolog
role
human
milk
compon
human
milk
contain
compound
form
polymer
nucleotid
nucleic
acid
wherea
formula
contain
nucleotid
supplement
monomer
form
tabl
nucleotid
seem
enhanc
intestin
develop
promot
iron
absorpt
modifi
lipid
metabol
nutrit
role
compound
perform
immunolog
function
promot
killer
cell
cytotox
interleukin
il
product
stimul
mononuclear
cell
infant
either
breastf
fed
nucleotidesuppl
formula
nucleotid
supplement
also
report
reduc
number
episod
infant
diarrhea
group
infant
lower
socioeconom
statu
chile
manner
analog
protect
afford
human
milk
report
nucleotidesuppl
formula
promot
immun
respons
infant
haemophilu
influenza
type
b
polysaccharid
immun
month
age
similar
respons
observ
diphtheria
immun
infant
fed
human
milk
month
show
similar
respons
exhibit
enhanc
titer
respons
oral
polio
vaccin
latter
respons
observ
group
fed
nucleotidesuppl
formula
nucleotid
emerg
nutrit
immunolog
compon
human
milk
note
nutrit
protein
human
milk
classifi
either
whey
acidsolubl
casein
acidprecipit
within
two
class
protein
sever
specif
protein
respons
support
nutrit
need
infant
human
casein
compos
primarili
bcasein
kcasein
although
actual
distribut
two
protein
unclear
contrast
bovin
milk
contain
casein
casein
neither
found
human
milk
addit
bcasein
kcasein
two
human
milk
casein
protein
seem
account
approxim
protein
found
human
milk
contrast
earlier
calcul
amount
commonli
use
prepar
reconstitut
socal
human
formula
bovin
milk
normal
contain
casein
protein
wheyprotein
fraction
contain
propos
function
protein
human
milk
immunoglobulin
lysozym
lactoferrin
enzym
cytokin
peptid
hormon
addit
major
nutrit
protein
alactalbumin
whey
protein
compos
approxim
human
milk
protein
contrast
bovin
milk
although
alactalbumin
major
whey
protein
human
milk
blactoglobulin
major
whey
protein
bovin
milk
found
human
milk
consist
fraction
human
milk
whey
protein
compos
serum
albumin
sourc
unclear
evid
indic
may
synthes
mammari
gland
serum
albumin
probabl
synthes
outsid
mammari
gland
howev
milk
protein
character
site
synthesi
speci
specif
protein
alactalbumin
blactoglobulin
speci
organ
specif
wherea
protein
serum
albumin
speci
specif
organ
specif
net
result
differ
protein
use
nutrit
neonat
differ
amount
amino
acid
ingest
neonat
depend
sourc
milk
even
reconstitut
whey
casein
class
protein
one
speci
ratio
similar
anoth
speci
result
ident
amino
acid
intak
differ
reflect
plasma
amino
acid
profil
infant
fed
commerci
milk
versu
human
milk
regardless
ratio
reconstitut
although
major
proport
human
milk
protein
compos
nutrit
protein
describ
mani
remain
protein
subserv
varieti
function
addit
nutrit
support
neonat
protein
includ
carrier
protein
enzym
hormon
growth
factor
immunoglobulin
cytokin
latter
two
discuss
later
resist
infect
whether
protein
still
function
ingest
neonat
alway
establish
clear
human
milk
suppli
mixtur
potenti
far
complex
nutrit
substrat
mani
nutrient
suppli
neonat
bound
protein
found
human
milk
bind
may
play
import
role
make
nutrient
bioavail
lactoferrin
ironbind
protein
properti
also
may
play
role
bacteriostat
action
appar
absorb
intact
infant
lactoferrin
may
import
improv
absorpt
iron
infant
human
milk
compar
iron
cow
milk
prepar
contain
littl
lactoferrin
lactoferrin
also
may
bind
miner
includ
zinc
manganes
although
prefer
miner
form
seem
ferric
ion
numer
protein
seem
import
carrier
vitamin
hormon
folatebind
vitamin
b
bind
vitamin
dbind
protein
identifi
human
milk
protein
appar
resist
proteolysi
especi
satur
appropri
vitamin
ligand
serum
albumin
act
carrier
numer
ligand
wherea
alactalbumin
act
carrier
calcium
final
protein
bind
thyroid
hormon
corticosteroid
report
present
human
milk
although
serum
albumin
may
partial
fulfil
function
activ
enzym
detect
human
milk
enzym
seem
origin
blood
origin
secretori
epitheli
cell
mammari
gland
littl
known
role
enzym
lysozym
lipas
human
milk
enzym
found
human
milk
rang
atpas
antioxid
enzym
catalas
phosphatas
glycolyt
enzym
although
enzym
import
role
normal
bodi
metabol
unclear
mani
either
function
milk
surviv
ingest
neonat
function
neonat
lysozym
seem
part
antibacteri
function
human
milk
wherea
lipas
nutrientrel
role
modul
fat
metabol
neonat
two
lipas
identifi
human
milk
lipoprotein
lipas
bile
saltstimul
lipas
lipoprotein
lipas
seem
involv
determin
pattern
lipid
found
human
milk
regul
uptak
milk
level
mammari
gland
human
milk
bile
saltstimul
lipas
acidst
protein
compens
low
activ
lipas
secret
digest
tract
earli
develop
two
enzym
regul
amount
pattern
lipid
appear
milk
extrem
effici
absorpt
lipid
infant
human
milk
lipid
absorb
much
readili
lipid
commerci
milk
formula
despit
mani
adapt
made
improv
absorpt
illustr
effect
mechan
support
lipas
peptid
steroid
hormon
growth
factor
identifi
trace
amount
human
milk
although
enzym
unclear
degre
function
neonat
ingest
milk
discuss
previous
bind
protein
corticosteroid
thyroxin
identifi
milk
extrapol
observ
milk
compon
may
play
role
make
bioactiv
compound
readili
avail
infant
among
hormon
identifi
human
milk
insulin
oxytocin
calcitonin
prolactin
hormon
appar
absorb
infant
role
vivo
function
unclear
breastf
infant
seem
differ
endocrin
respons
formulaf
infant
presum
reflect
intak
hormon
human
milk
advantag
disadvantag
infant
respons
unknown
human
milk
also
contain
rich
mixtur
growth
factor
includ
epiderm
growth
factor
nerv
growth
factor
transform
growth
factorb
addit
variou
gastrointestin
peptid
identifi
human
milk
presum
suppli
variou
factor
infant
milk
compens
possibl
defici
infant
earli
develop
composit
human
milk
provid
complex
complet
nutrit
substrat
neonat
human
milk
suppli
individu
nutrient
also
enzym
involv
metabol
carrier
improv
absorpt
hormon
may
regul
metabol
rate
commerci
formula
yet
develop
point
provid
analog
complet
nutrit
system
mani
benefit
human
milk
evid
term
neonat
also
evid
preterm
neonat
low
birth
weight
g
fed
unfortifi
human
milk
incid
necrot
enterocol
also
seem
reduc
nonetheless
content
calcium
phosphoru
protein
sodium
vitamin
energi
unfortifi
human
milk
may
inadequ
meet
need
low
birth
weight
preterm
neonat
use
exclus
sourc
nutrient
unfortifi
human
milk
may
associ
impair
growth
nutrient
defici
metaanalysi
studi
compar
prematur
infant
fed
unfortifi
fortifi
human
milk
found
fortifi
milk
associ
greater
increas
weight
length
head
circumfer
better
nitrogen
balanc
bone
miner
content
without
increas
feed
intoler
complic
feed
fortifi
human
milk
seem
associ
substanti
increas
rate
feed
intoler
reduct
benefici
effect
human
milk
rate
infect
necrot
enterocol
qualiti
data
regard
util
fortifi
human
milk
still
limit
howev
addit
research
need
defin
better
mean
provid
benefit
human
milk
preterm
infant
meet
specif
nutrit
requir
fresh
human
milk
contain
wealth
compon
provid
specif
nonspecif
defens
infecti
agent
environment
macromolecul
tabl
compon
factor
includ
cell
b
lymphocyt
polymorphonuclear
neutrophil
ie
polymorphonuclear
leukocyt
macrophag
solubl
product
especi
immunoglobulin
secretori
immunoglobulin
siga
immunomodulatori
cytokin
cytokin
receptor
compon
complement
system
sever
carrier
protein
enzym
numer
endocrin
hormon
hormonelik
substanc
addit
solubl
factor
activ
streptococci
staphylococci
tumor
virus
also
identifi
epiderm
growth
factor
promot
growth
mucos
epithelium
matur
intestin
brush
border
development
characterist
siga
studi
extens
compon
basi
avail
inform
igaproduc
cell
observ
milk
origin
precursor
immunocompet
cell
gutassoci
lymphoid
tissu
galt
bronchusassoci
lymphoid
tissu
balt
exposur
iga
precursor
b
lymphocyt
galt
balt
microbi
dietari
antigen
mucos
lumen
import
prerequisit
initi
activ
prolifer
antigensensit
cell
eventu
transport
system
circul
mucos
surfac
includ
mammari
gland
plasma
cell
initi
synthesi
immunoglobulin
specif
antigen
previous
experienc
mucosa
respiratori
alimentari
tract
propos
cell
observ
milk
also
may
deriv
galt
balt
manner
similar
igaproduc
cell
littl
inform
avail
regard
site
origin
cellular
solubl
immunolog
compon
normal
present
human
milk
specif
antibodi
cellular
immun
reactiv
mani
respiratori
enter
bacteri
viral
pathogen
ingest
food
protein
also
present
human
breast
milk
tabl
observ
peripher
mucos
site
major
class
immunoglobulin
human
colostrum
milk
siga
iga
igg
igm
igd
igealso
present
iga
exist
dimer
two
iga
molecul
link
togeth
polypeptid
chain
jchain
associ
nonimmunoglobulin
protein
refer
secretori
compon
siga
protein
constitut
total
nitrogen
content
human
milk
iga
dimer
produc
plasma
cell
basal
surfac
mammari
epithelium
bound
polymer
immunoglobulin
receptor
basolater
surfac
mammari
epitheli
cell
transport
cell
releas
alveolar
space
iga
dimer
associ
portion
polymer
immunoglobulin
receptor
refer
secretori
compon
sequenti
quantit
classspecif
immunoglobulin
human
colostrum
milk
shown
highest
level
siga
igm
present
first
day
lactat
fig
level
iga
time
greater
level
igm
time
greater
level
igg
time
greater
level
serum
iga
lactat
progress
iga
declin
level
mg
per
gram
protein
igm
level
declin
decreas
balanc
increas
volum
milk
produc
process
lactat
becom
establish
tabl
iga
antibodi
found
milk
possess
specif
infecti
agent
endem
pathogen
intestin
respiratori
tract
see
tabl
antibodi
may
present
milk
absenc
specif
circul
iga
studi
pregnant
women
given
oral
feed
escherichia
coli
develop
iga
antibodi
human
milk
evid
absenc
detect
serum
antibodyspecif
respons
anoth
studi
investig
observ
similar
respons
anim
model
use
intrabronchi
immun
streptococcu
pneumonia
studi
strongli
support
concept
bronchomammari
enteromammari
axi
immunolog
reactiv
breast
despit
eleg
studi
defin
mechan
iga
cell
traffick
galt
balt
mammari
gland
actual
number
b
cell
iga
plasma
cell
mammari
gland
spars
colostrum
milk
may
contain
larg
amount
iga
g
colostrum
g
per
day
later
milk
shown
tabl
reason
underli
appar
dispar
content
immunoglobulinproduc
cell
concentr
immunoglobulin
unknown
dispar
may
relat
uniqu
hormon
environ
mammari
gland
hormon
consist
observ
human
milk
list
tabl
effect
pregnancyrel
lactationrel
hormon
regul
immunolog
reactiv
present
rest
lactat
breast
examin
studi
immunoglobulin
product
nonlact
human
breast
sever
interest
find
note
mononuclear
cell
present
nonlact
breast
nullipar
parou
women
although
igacontain
cell
predomin
synthesi
iga
seem
slightli
increas
parou
women
iga
found
mammari
tissu
prolif
stage
menstrual
cycl
nullipar
women
luteal
phase
parou
women
number
igaproduc
cell
nonlact
breast
observ
increas
pariti
find
suggest
immunolog
makeup
nonlact
lactat
breast
may
significantli
influenc
hormon
milieu
anoth
studi
virgin
mice
given
exogen
administ
hormon
extend
exposur
estrogen
progesteron
prolactin
necessari
maxim
increment
igaproduc
plasma
cell
breast
similarli
castrat
male
expos
hormon
becam
moder
recept
mammari
gland
home
cell
specif
iga
synthesi
would
expect
testosteron
elimin
femal
breast
recept
cell
studi
suggest
exist
hormon
determin
home
mechan
mammari
gland
classspecif
immunoglobulinproduc
cell
recent
studi
propos
anoth
possibl
influenc
lactat
hormon
immunocompet
cell
limit
observ
combin
prolactin
estrogen
progesteron
concentr
observ
normal
begin
parturit
seem
amplifi
effect
synthesi
secret
iga
peripher
blood
lymphocyt
observ
rais
possibl
high
level
siga
observ
colostrum
milk
may
partli
result
select
hormon
mediat
prolifer
antigensensit
iga
cell
peripher
blood
immunoglobulin
could
acquir
secretori
compon
passag
mammari
epithelium
eventu
appear
colostrum
milk
matur
siga
although
appear
siga
antibodi
milk
characterist
follow
antigen
exposur
galt
balt
precis
natur
iga
content
milk
seem
determin
variou
factor
oper
mucos
lymphoid
tissu
factor
includ
dendrit
cell
regulatori
tcell
network
galt
possibl
balt
natur
antigen
solubl
protein
versu
particul
microbi
agent
rout
primari
versu
secondari
antigen
exposur
estim
breastf
infant
may
consist
receiv
g
iga
day
approxim
amount
igm
igg
estim
lactat
immunoglobulin
deliv
breastf
infant
differ
period
lactat
present
tabl
ingest
iga
elimin
fece
although
may
absorb
intestin
circul
within
first
hour
birth
fece
breastf
infant
contain
function
antibodi
present
ingest
milk
studi
support
find
prolong
surviv
milk
iga
gastrointestin
tract
infant
fed
human
milk
shown
presenc
immunoglobulin
class
fece
fecal
iga
content
three
four
time
greater
igm
human
milk
feed
compar
studi
surviv
human
milk
iga
bovin
igg
neonat
intestin
tract
suggest
fecal
content
iga
may
time
greater
human
milk
feed
bovin
igg
feed
bovin
immunoglobulin
endogen
product
siga
infant
mucos
immun
system
increas
progress
postnat
period
nonetheless
breastf
infant
substanti
greater
concentr
fecal
siga
formulaf
infant
prentic
colleagu
found
approxim
approxim
higher
concentr
siga
stool
breastf
infant
compar
formulaf
infant
week
postnat
age
even
though
approxim
ingest
siga
appear
fece
direct
inform
role
milk
iga
antimicrobi
defens
avail
sever
studi
siga
interfer
bacteri
adher
cell
surfac
colostrum
milk
inhibit
activ
e
coli
vibrio
cholera
enterotoxin
experiment
set
antitox
activ
human
milk
seem
correl
well
iga
content
igm
igg
content
precoat
v
cholera
specif
siga
protect
infant
mice
diseas
similar
result
obtain
use
specif
purifi
milk
siga
prevent
e
coliinduc
shigella
dysenteriaeinduc
diseas
rabbit
less
definit
suggest
studi
conduct
human
milk
feed
rel
intestin
replic
oral
administ
live
polioviru
vaccin
studi
found
breastfeed
may
reduc
degre
seroconvers
polioviru
antibodi
vaccin
infant
antipolio
iga
present
human
milk
colostrum
investig
conclud
specif
iga
may
bind
polioviru
influenc
viral
replic
intestin
mucosa
extens
experi
oral
polio
immun
worldwid
found
convinc
associ
howev
breastfeed
live
vaccin
failur
studi
shown
magnitud
polioviru
replic
intestin
determin
presenc
level
preexist
siga
antibodi
high
level
intestin
iga
antibodi
littl
replic
vaccin
viru
observ
gut
lower
level
vari
degre
viral
replic
could
shown
epidemiolog
studi
strongli
support
notion
breastfeed
protect
infant
infecti
diseas
see
benefit
risk
human
milk
imposs
studi
howev
dissect
rel
contribut
siga
contribut
solubl
cellular
compon
present
colostrum
milk
normal
neonat
exhibit
characterist
pauciti
lack
serum
iga
siga
first
day
birth
time
presenc
igm
igg
milk
may
import
compens
immunolog
function
present
mucos
site
igg
igm
particip
complement
fixat
specif
bactericid
activ
function
associ
iga
studi
done
oral
feed
immun
serum
globulin
mostli
igg
suggest
igg
may
surviv
gastrointestin
tract
infant
low
birth
weight
immunoglobulin
isotyp
milk
also
may
abl
serv
effect
substitut
iga
neonat
igadefici
mother
prevent
infect
enter
respiratori
pathogen
investig
fail
show
local
synthesi
ige
breast
although
ige
may
detect
colostrum
milk
sampl
concentr
extrem
low
mani
sampl
colostrum
milk
contain
ige
activ
pair
sampl
serum
contain
high
ige
level
igd
detect
colostrum
milk
sampl
suggest
nurs
women
high
serum
igd
level
like
high
igd
concentr
milk
possibl
local
product
ige
igd
rule
human
colostrum
milk
contain
lymphocyt
monocytesmacrophag
neutrophil
epitheli
cell
earli
colostrum
contain
highest
concentr
cell
approxim
cellsml
end
first
week
lactat
cell
concentr
order
cellsml
total
cell
number
deliv
newborn
throughout
lactat
may
remain
constant
howev
adjust
made
increas
volum
milk
produc
two
major
cell
popul
human
milkmacrophag
neutrophilsar
difficult
distinguish
common
stain
method
numer
intracytoplasm
inclus
accur
estim
made
flow
cytometri
analysi
suggest
rel
percentag
neutrophil
macrophag
lymphocyt
earli
milk
sampl
approxim
remain
cell
present
smaller
amount
especi
absenc
activ
suckl
engorg
local
breast
infect
histochem
milk
macrophag
differ
blood
monocyt
show
decreas
peroxidas
stain
increas
lysosom
signific
amount
immunoglobulin
especi
iga
cytoplasm
intracellular
immunoglobulin
macrophag
repres
milk
iga
kinet
studi
releas
iga
human
milk
macrophag
suggest
immunoglobulin
releas
macrophag
contrast
immunoglobulin
releas
phagocyt
cell
timedepend
phenomenon
significantli
influenc
use
secretagogu
stimul
phorbol
myrist
acet
activ
phagocytosi
associ
howev
signific
increas
releas
iga
precis
function
macrophag
colostrum
milk
fulli
explor
cell
suggest
potenti
transport
vehicl
iga
milk
macrophag
possess
phagocyt
activ
staphylococcu
aureu
e
coli
candida
albican
possibl
cytocid
activ
first
two
organ
milk
macrophag
particip
antibodydepend
cellmedi
cytotox
herp
simplex
viru
type
cell
infect
milk
macrophag
respiratori
syncyti
viru
result
product
proinflammatori
cytokin
tumor
necrosi
factor
tnf
cell
also
involv
variou
biosynthet
excretori
activ
includ
product
lactoferrin
lysozym
compon
complement
properdin
factor
b
epitheli
growth
factor
lymphocytesuppress
factor
milk
macrophag
also
suggest
import
regul
tcell
function
milk
contain
lymphocyt
cell
b
cell
small
number
b
cell
reflect
sessil
natur
cell
enter
lamina
propria
mammari
gland
transform
plasma
cell
although
sever
investig
unabl
show
vitro
antibodi
synthesi
milk
lymphocyt
studi
perform
colostr
b
cell
transform
epsteinbarr
viru
show
product
igg
jchaincontain
igm
iga
small
popul
natur
killer
nk
cell
also
identifi
milk
sampl
accur
quantit
function
studi
colostr
cell
exhibit
nk
cytotox
howev
enhanc
interferon
ifn
colostr
cell
also
elicit
antibodydepend
lectindepend
cellular
cytotox
respons
nk
antibodydepend
lectindepend
respons
colostr
cell
observ
significantli
lower
autolog
peripher
blood
cell
reduc
cellular
cytotox
colostr
cell
also
observ
virusinfect
target
certain
bacteria
sever
specif
virusinfect
target
colostrum
milk
cell
conspicu
lack
cellular
cytotox
compar
autolog
peripher
blood
cell
also
appar
exclus
cytolyt
cell
milk
specif
certain
human
leukocyt
antigen
hla
lymphocyt
colostrum
milk
matur
cell
helper
cytotox
popul
present
human
milk
proport
cell
higher
found
human
blood
tabl
ratio
milk
significantli
lower
ratio
observ
peripher
blood
due
increas
cell
peripher
blood
women
postpartum
period
colostr
milk
lymphocyt
manifest
vitro
prolif
respons
stimul
numer
mitogen
antigen
sever
studi
shown
select
lymphocyt
stimul
respons
colostr
milk
lymphocyt
variou
antigen
compar
peripher
blood
lymphocyt
respons
antigen
rubella
viru
stimul
lymphocyt
secretori
site
milk
system
site
contrast
e
coli
antigen
whose
exposur
limit
mucos
site
produc
stimul
lymphoprolif
respons
milk
lymphocyt
find
support
concept
select
tcell
popul
mammari
gland
addit
antigen
select
gener
hyporespons
mitogen
stimul
milk
lymphocyt
rel
peripher
blood
lymphocyt
observ
decreas
reactiv
milk
lymphocyt
phytohemagglutinin
may
partli
result
rel
defici
certain
popul
cell
milk
macrophaget
cell
interact
also
postul
respons
rel
hyporespons
although
unknown
whether
effect
result
decreas
helper
increas
regulatori
function
studi
shown
milk
lymphocyt
exhibit
reduc
respons
allogen
cell
display
good
abil
stimul
alloreact
gener
tcell
prolif
respons
phytohemagglutinin
tetanu
toxoid
breastf
infant
seem
significantli
higher
respons
bottlef
infant
possibl
secondari
presenc
matern
deriv
cell
growth
factor
lymphokin
human
milk
virtual
cell
milk
bear
isoform
associ
immunolog
memori
addit
proport
cell
display
phenotyp
marker
activ
includ
hladr
much
greater
blood
consist
memori
phenotyp
cell
human
milk
produc
ifng
significantli
greater
number
cell
colostrum
express
ligand
help
cell
provid
help
bcell
antibodi
product
macrophag
activ
see
chapter
detail
compar
autolog
heterolog
blood
cell
function
memori
cell
recipi
human
infant
current
unknown
howev
mucou
membran
site
alimentari
respiratori
tract
recipi
infant
would
seem
potenti
entri
site
human
milk
leukocyt
memori
cell
detect
blood
infanc
possibl
matern
memori
cell
milk
may
help
compens
development
delay
product
infant
proport
lymphocyt
bear
gd
tcell
receptor
gdtcr
approxim
two
time
greater
colostrum
blood
human
gdtcr
cell
popul
organ
lymphoid
tissu
repres
half
intraepitheli
lymphocyt
gut
intestin
epithelia
may
select
affin
gdtcr
cell
provid
favor
environ
matern
cell
milk
transfer
breastf
infant
evid
experiment
anim
studi
indic
milk
lymphocyt
enter
tissu
neonat
shown
human
human
possibl
transfer
matern
tcell
reactiv
tuberculin
protein
mother
neonat
process
breastfeed
suggest
implic
observ
matern
cellular
product
solubl
mediat
cellular
reactiv
may
transfer
passiv
neonat
breastfeed
occurr
phenomena
human
studi
care
direct
evid
milk
cell
either
abtcr
gdtcr
play
role
transfer
adopt
immunoprotect
recipi
infant
similarli
present
evid
suggest
immunolog
risk
human
neonat
matern
cell
ingest
breastfeed
milk
contain
numer
neutrophil
although
absolut
count
activ
nurs
mother
exhibit
consider
variabl
among
differ
sampl
highest
number
gener
observ
first
day
lactat
number
neutrophil
decreas
significantli
week
lactat
rare
neutrophil
observ
sampl
collect
day
postpartum
leukocyt
human
milk
seem
metabol
activ
although
neutrophil
phagocyt
produc
toxic
oxygen
radic
respond
well
chemoattract
increas
adher
polar
direct
migrat
vitro
system
diminish
respons
found
due
prior
activ
neutrophil
milk
display
phenotyp
pattern
typic
activ
neutrophil
express
chain
subunit
increas
express
lselectin
decreas
basi
anatom
distribut
epitheli
cell
human
mammari
gland
classifi
two
main
type
myoepitheli
lumin
epitheli
cell
type
seem
heterogen
howev
histolog
physicochem
test
includ
secretori
cell
contain
abund
rough
endoplasm
reticulum
lipid
droplet
golgi
apparatu
secretori
cell
appar
produc
casein
micel
squamou
epitheli
cell
usual
seen
region
cutan
junction
nippl
especi
near
galactophor
ductal
lumin
cell
exist
cluster
mani
short
microvilli
tight
junction
remnant
desmosom
human
milk
rel
epitheli
cell
observ
earli
phase
lactat
epitheli
cell
appear
week
seen
appreci
number
even
day
onset
lactat
possibl
except
synthesi
secretori
compon
casein
possibl
product
secretori
epitheli
cell
associ
stroma
mammari
gland
role
epitheli
cell
milk
remain
defin
inform
review
far
provid
strong
evid
exist
numer
dynam
cellular
reaction
mammari
gland
colostrum
milk
specif
function
role
collect
individu
epitheli
cell
monocyt
neutrophil
lymphocyt
mammari
gland
milk
remain
defin
view
high
degre
select
differ
quantit
function
distribut
cellular
element
suggest
mammari
gland
similar
mucos
surfac
may
function
partit
cellular
element
peripher
blood
manner
similar
peripher
site
eg
genit
tract
mucos
immun
system
unknown
howev
whether
characterist
proport
macrophag
lymphocyt
cytotox
cell
epitheli
cell
design
specif
function
local
mammari
gland
lactat
mother
epithelium
lumen
intestin
respiratori
mucosa
breastfeed
infant
observ
transfer
delay
hypersensit
reaction
human
neonat
graftversushost
reactiv
rat
rais
possibl
milk
cell
may
function
import
vehicl
transfer
matern
immun
neonat
potenti
benefici
harm
role
cellmedi
transfer
mucos
rout
need
investig
pauciti
nk
cytotox
cell
colostrum
may
role
breastfeed
neonat
especi
influenc
antigen
process
uptak
replic
microorgan
immun
respons
system
mucos
level
although
elucid
function
cellular
element
mammari
gland
suckl
neonat
need
like
presenc
milk
repres
highli
select
phenomenon
mere
contamin
peripher
blood
cell
defens
agent
human
milk
although
biochem
divers
share
follow
featur
usual
common
mucos
site
adapt
resist
digest
gastrointestin
tract
recipi
infant
protect
noninflammatori
mechan
act
synergist
factor
produc
infant
compon
immun
system
human
milk
produc
throughout
lactat
gradual
wean
often
invers
relationship
product
factor
mammari
gland
product
infant
time
frame
lactat
postnat
develop
lactat
proce
concentr
mani
factor
human
milk
declin
concomitantli
mucos
product
factor
increas
develop
infant
whether
invers
relationship
process
due
feedback
mechan
process
independ
unclear
human
milk
contain
sever
oligosaccharid
glycoconjug
includ
monosialogangliosid
receptor
analogu
heatlabil
toxin
produc
v
cholera
e
coli
fucosecontain
oligosaccharid
inhibit
hemagglutinin
activ
classic
strain
v
cholera
fucosyl
oligosaccharid
protect
heatstabl
enterotoxin
e
coli
mannosecontain
highmolecularweight
glycoprotein
block
bind
el
tor
strain
v
cholera
glycoprotein
glycolipid
interfer
bind
colon
factor
cfaii
fimbria
enterotoxigen
e
coli
inhibit
toxin
bind
associ
acid
glycolipid
contain
sialic
acid
gangliosid
although
quantiti
total
gangliosid
human
milk
bovin
milk
similar
rel
frequenc
type
gangliosid
milk
two
speci
distinct
type
monosialyl
oligosaccharid
identifi
human
milk
new
type
still
recogn
monosialogangliosid
constitut
total
gangliosid
human
milk
percentag
much
lower
bovin
milk
also
level
enterotoxin
receptor
gangliosid
g
time
greater
human
milk
bovin
milk
differ
may
clinic
import
g
inhibit
enterotoxin
e
coli
v
cholera
also
intact
human
milk
fat
globul
mucin
membran
structur
inhibit
bind
sfimbriat
e
coli
human
buccal
epitheli
cell
oligosaccharid
human
milk
also
interfer
attach
h
influenza
pneumonia
regard
nacetylglucosamin
galdisaccharid
subunit
block
attach
pneumonia
respiratori
epithelium
human
milk
interfer
bind
human
immunodefici
viru
hiv
envelop
antigen
molecul
cell
evid
anim
model
suggest
oligosaccharid
glycoconjug
human
milk
protect
vivo
relev
clinic
data
scarc
transmiss
hiv
breastfeed
wellestablish
mean
mothertoinf
transmiss
hiv
see
benefit
risk
human
milk
addit
direct
antimicrobi
effect
carbohydr
human
milk
nitrogencontain
oligosaccharid
glycoprotein
glycopeptid
growth
promot
lactobacillu
bifidu
var
pennsylvanicu
abil
human
milk
promot
growth
l
bifidu
may
resid
oligosaccharid
moieti
peptid
casein
seem
factor
respons
great
extent
howev
predomin
lactobacillu
speci
bacteri
flora
larg
intestin
breastf
infant
bacteria
produc
larg
amount
acet
acid
aid
suppress
multipl
enteropathogen
also
report
lactobacillu
speci
strain
gg
aid
recoveri
acut
rotaviru
infect
may
enhanc
format
circul
cell
produc
specif
antibodi
igg
iga
igm
isotyp
serum
level
antibodi
human
milk
suppli
defens
agent
fat
partial
digest
recipi
alimentari
tract
fatti
acid
monoglycerid
produc
milk
fat
bile
saltstimul
lipas
lipoprotein
lipas
human
milk
lingualgastr
lipas
neonat
birth
pancreat
lipas
week
age
abl
disrupt
envelop
virus
antivir
lipid
may
aid
prevent
coronaviru
infect
intestin
tract
may
defend
intestin
parasit
giardia
lamblia
entamoeba
histolytica
princip
protein
human
milk
direct
antimicrobi
properti
includ
follow
alactalbumin
major
compon
milk
protein
may
possess
import
function
immunolog
defens
protein
appear
larg
complex
sever
alactalbumin
molecul
induc
apoptosi
transform
embryon
lymphoid
cell
line
lactoferrin
domin
whey
protein
human
milk
singlechain
glycoprotein
two
globular
lobe
display
site
bind
ferric
iron
lactoferrin
human
milk
form
apolactoferrin
ie
contain
ferric
iron
compet
siderophil
bacteria
fungi
ferric
iron
disrupt
prolifer
microbi
pathogen
epitheli
growthpromot
activ
lactoferrin
human
milk
also
may
aid
defens
recipi
infant
mean
concentr
lactoferrin
human
colostrum
mgml
volum
milk
product
increas
concentr
decreas
mgml
month
lactat
resist
proteolysi
excret
lactoferrin
stool
higher
infant
fed
human
milk
infant
fed
cow
milk
mean
intak
milk
lactoferrin
per
day
healthi
breastf
fullterm
infant
mgkg
month
lactat
mgkg
month
quantiti
lactoferrin
excret
stool
lowbirthweight
infant
fed
human
milk
approxim
time
excret
stool
infant
fed
cow
milk
formula
estim
may
high
howev
presenc
immunoreact
fragment
lactoferrin
stool
infant
fed
human
milk
consist
suggest
prentic
colleagu
found
approxim
lactoferrin
ingest
breast
milk
excret
intact
stool
week
postnat
age
addit
signific
increment
urinari
excret
intact
fragment
lactoferrin
occur
result
human
milk
feed
stabl
isotop
studi
suggest
increment
urinari
lactoferrin
fragment
princip
ingest
human
milk
lactoferrin
rel
high
concentr
lysozym
singlechain
protein
present
human
milk
agent
lyse
suscept
bacteria
hydrolyz
linkag
nacetylmuram
acid
residu
cell
wall
lysozym
rel
resist
digest
trypsin
denatur
owe
acid
mean
concentr
lysozym
mgml
colostrum
mgml
month
lactat
mgml
month
approxim
mean
daili
intak
milk
lysozym
healthi
fullterm
complet
breastf
infant
mgkg
month
lactat
mgkg
month
studi
conduct
examin
fate
human
milk
lysozym
ingest
infant
amount
lysozym
excret
stool
lowbirthweight
infant
fed
human
milk
approxim
eight
time
amount
excret
stool
infant
fed
cow
milk
formula
urinari
excret
protein
increas
result
human
milk
feed
fibronectin
highmolecularweight
protein
facilit
uptak
mani
type
particul
mononuclear
phagocyt
cell
present
human
milk
mean
concentr
colostrum
mgl
vivo
effect
fate
broadspectrum
opsonin
human
milk
unknown
compon
classic
altern
pathway
complement
present
human
milk
concentr
compon
except
except
low
although
direct
antiinflammatori
effect
human
milk
shown
vivo
numer
clinic
observ
suggest
breastfeed
protect
recipi
infant
injuri
intestin
respiratori
mucosa
protect
may
partli
due
rapid
elimin
neutral
microbi
pathogen
lumen
gastrointestin
tract
specif
broadspectrum
defens
agent
human
milk
featur
human
milk
suggest
sole
explan
proinflammatori
mediat
poorli
repres
human
milk
contrast
human
milk
contain
host
antiinflammatori
agent
includ
heterogen
group
growth
factor
cytoprotect
trophic
activ
mucos
epithelium
antioxid
antiproteas
cytokin
cytokin
receptor
antagonist
bioactiv
agent
inhibit
inflammatori
mediat
block
select
activ
leukocyt
similar
antimicrobi
factor
factor
well
adapt
oper
hostil
environ
recipi
alimentari
tract
growth
factor
human
milk
includ
epiderm
growth
factor
transform
growth
factora
transform
growth
factorb
lactoferrin
polyamin
host
hormon
includ
insulinlik
growth
factor
vascular
endotheli
growth
factor
growth
hormonereleas
factor
hepatocyt
growth
factor
prolactin
leptin
cortisol
may
affect
growth
matur
epitheli
barrier
limit
penetr
pathogen
microorgan
free
antigen
prevent
allerg
sensit
corticosteron
glucocorticoid
present
high
concentr
rat
milk
speed
gut
closur
neonat
rat
although
macromolecular
absorpt
seem
mark
human
neonat
function
mucos
barrier
system
earli
infanc
import
host
defens
system
may
affect
factor
human
milk
regard
matur
intestin
tract
measur
mucos
mass
dna
protein
content
small
intestin
tract
seem
influenc
milk
particularli
earli
milk
secret
antioxid
activ
colostrum
shown
associ
ascorb
compound
uric
acid
addit
two
antioxid
present
human
milk
atocopherol
bcaroten
absorb
circul
recipi
gastrointestin
mucosa
serum
vitamin
e
concentr
increas
breastf
infant
mean
mgml
birth
approxim
mgml
day
life
high
concentr
pleiotrop
antiinflammatori
immunoregulatori
cytokin
attenu
dendrit
cell
macrophag
tcell
nkcell
function
shown
sampl
human
milk
collect
first
hour
lactat
present
aqueou
phase
milk
also
lipid
layer
bioactiv
properti
confirm
find
human
milk
sampl
inhibit
blood
lymphocyt
prolifer
properti
greatli
reduc
treatment
antibodi
mice
target
disrupt
gene
rais
convent
hous
condit
spontan
develop
gener
enterocol
becom
appar
age
week
time
wean
observ
suggest
rat
milk
perhap
human
milk
may
play
crucial
role
homeostasi
immatur
intestin
barrier
regul
aberr
immun
respons
foreign
antigen
solubl
cytokin
receptor
cytokin
receptor
antagonist
also
potent
antiinflammatori
agent
human
colostrum
matur
milk
shown
contain
biolog
activ
level
receptor
antagonist
solubl
tnfa
receptor
ii
stnfari
stnfarii
vivo
relev
observ
also
shown
chemic
induc
coliti
model
rat
anim
coliti
fed
human
milk
significantli
lower
neutrophil
inflamm
anim
fed
either
chow
infant
formula
similar
protect
effect
seen
rat
coliti
fed
infant
formula
supplement
suggest
antiinflammatori
agent
present
milk
may
contribut
broad
protect
differ
injuri
provid
human
milk
feed
presenc
human
milk
plateletactiv
factor
acetylhydrolas
pafah
enzym
catalyz
degrad
inactiv
paf
intrigu
elev
serum
concentr
paf
found
rat
human
neonat
necrot
enterocol
wherea
concentr
pafah
found
significantli
lower
control
unaffect
neonat
serum
concentr
pafah
birth
less
concentr
adult
gradual
increas
enzym
activ
transfer
mucos
seros
fluid
intestin
neonat
rat
particularli
earliest
postnat
period
antiinflammatori
factor
present
human
milk
includ
igebind
factor
relat
antigen
fcerii
lower
affin
receptor
ige
suppress
vitro
synthesi
human
ige
glycophosphoinositolcontain
molecul
protectin
inhibit
insert
complement
membran
attack
complex
cell
target
vivo
fate
effect
antiinflammatori
factor
human
milk
still
poorli
understood
sever
seemingli
unrel
type
observ
suggest
breastfeed
modul
develop
immun
system
recipi
infant
l
prospect
retrospect
epidemiolog
studi
shown
breastf
infant
less
risk
develop
certain
chronic
immunolog
mediat
disord
later
childhood
includ
allerg
diseas
crohn
diseas
ulcer
coliti
insulindepend
diabet
mellitu
lymphoma
l
humor
cellular
immun
respons
specif
antigen
ie
vaccin
given
first
year
life
seem
develop
differ
breastf
formulaf
infant
sever
studi
report
increas
serum
antibodi
titer
h
influenza
type
b
polysaccharid
oral
polioviru
tetanu
diphtheria
toxoid
immun
breastf
infant
regard
cellmedi
immun
breastf
infant
given
bacil
vaccin
birth
later
show
significantli
higher
lymphocyt
transform
respons
purifi
protein
deriv
infant
never
breastf
matern
renal
allograft
surviv
better
individu
breastf
individu
respect
vitro
allogen
respons
blood
lymphocyt
mother
stimul
cell
infant
respond
cell
measur
analysi
frequenc
cytotox
lymphocyt
ctl
precursor
direct
hla
alloantigen
ctl
allorepertoir
low
breastf
infant
l
increas
level
certain
immun
factor
breastf
infant
could
explain
simpli
passiv
transfer
substanc
also
suggest
immunomodulatori
activ
human
milk
breastf
infant
produc
higher
blood
level
ifn
respons
respiratori
syncyti
viru
infect
also
found
increment
blood
level
fibronectin
achiev
breastfeed
could
due
amount
protein
human
milk
addit
found
human
milk
feed
led
rapid
develop
appear
siga
extern
secret
urin
far
remov
anatom
rout
ingest
l
breast
milk
inhibit
respons
human
adult
fetal
intestin
epitheli
cell
dendrit
cell
monocyt
ligandinduc
activ
tolllik
receptor
augment
activ
via
inhibit
activ
via
seem
mediat
solubl
form
receptor
wherea
augment
signal
associ
yet
uncharacter
protein
immunomodulatori
activ
present
infant
formula
result
suggest
breast
milk
modul
gut
innat
immun
recognit
respons
microb
may
affect
natur
gut
microbi
flora
eg
microbiom
risk
diseas
earli
later
life
observ
suggest
abil
human
milk
modul
develop
infant
mucos
system
immun
system
may
associ
immunoregulatori
factor
present
colostrum
matur
milk
sever
differ
type
immunomodulatori
agent
identifi
human
milk
among
numer
substanc
proven
potenti
abil
modul
infant
immun
respons
prolactin
atocopherol
lactoferrin
nucleotid
antiidiotyp
siga
cytokin
evid
mani
factor
milk
primari
biolog
function
case
hormon
growth
factor
potenti
immunoregulatori
agent
overlap
antimicrobi
antiinflammatori
properti
sever
cytokin
chemokin
growth
factor
mediat
effector
phase
natur
specif
immun
discov
human
milk
mani
identifi
subsequ
tabl
human
milk
display
numer
biolog
activ
characterist
cytokin
includ
stimul
growth
differenti
immunoglobulin
product
b
cell
enhanc
thymocyt
prolifer
inhibit
product
cell
suppress
ige
product
tnfa
first
two
cytokin
quantifi
human
milk
colostrum
tnfa
present
mainli
fraction
molecular
weight
kda
probabl
bound
solubl
receptor
milk
tnfa
secret
milk
macrophag
mammari
epithelium
first
shown
human
milk
specif
bioassay
studi
antibodi
inhibit
iga
product
colostrum
mononuclear
cell
suggest
may
involv
product
iga
mammari
gland
presenc
milk
also
shown
immunoassay
similarli
local
highmolecularweight
fraction
human
milk
associ
receptor
studi
milk
although
express
receptor
mammari
epithelium
secret
form
milk
may
explain
high
molecular
weight
cytokin
human
milk
express
messeng
ribonucl
acid
mrna
protein
milk
cell
mammari
gland
epithelium
suggest
milk
mononuclear
cell
mammari
gland
like
major
sourc
cytokin
presenc
ifng
human
milk
also
report
although
investig
found
signific
level
ifng
milk
sampl
obtain
mother
whose
infant
deliv
cesarean
section
signific
observ
unclear
present
ifng
bioactiv
associ
specif
subset
milk
cell
also
remain
determin
presenc
possibl
function
human
milk
discuss
antiinflammatori
agent
chemokin
novel
class
small
cytokin
discret
target
cell
select
abl
recruit
activ
differ
popul
leukocyt
see
chapter
chemokin
group
famili
defin
space
cystein
residu
see
chapter
cxc
chemokin
cystein
pair
separ
one
amino
acid
cc
chemokin
pair
cystein
adjac
found
human
milk
certain
cxc
chemokin
contain
elr
motif
includ
also
known
groa
predominantli
attract
neutrophil
wherea
basophil
eosinophil
dendrit
cell
monocyt
specif
subset
b
lymphocyt
attract
specif
cc
chemokin
nonelr
cxc
chemokin
presenc
mani
cxc
cc
chemokin
describ
human
milk
see
tabl
colonystimul
factorshighli
specif
protein
factor
regul
cell
prolifer
differenti
process
hematopoiesisar
also
present
human
milk
concentr
monocyt
colonystimul
factor
particular
seem
higher
human
milk
serum
monocyt
colonystimul
factor
evid
produc
epitheli
cell
duct
alveoli
mammari
gland
regulatori
activ
femal
sex
hormon
although
tempt
specul
cytokin
present
milk
may
abl
interact
mucos
tissu
respiratori
alimentari
tract
recipi
infant
function
express
specif
receptor
cytokin
epitheli
lymphoid
cell
airway
gastrointestin
mucosa
fulli
explor
receptorindepend
mechan
cytokin
uptak
gastrointestin
mucosa
neonat
period
shown
date
whether
extent
cytokin
breast
milk
contribut
benefici
effect
human
milk
gut
elsewher
larg
unknown
indirect
evid
suggest
growth
factor
tcell
progenitor
memori
cell
breast
milk
may
support
thymic
growth
thymu
size
found
larger
breastf
formulaf
infant
denmark
thymu
size
content
breast
milk
directli
correl
exclus
breastf
infant
gambia
latter
studi
reduc
breast
milk
content
observ
hungri
season
associ
reduc
thymu
size
thymic
product
cell
howev
whether
breast
milk
absorb
intact
causal
relat
greater
thymu
size
mere
surrog
factor
determin
studi
sever
investig
examin
effect
prematur
earli
wean
galactorrhea
matern
malnutrit
process
lactat
immunolog
aspect
studi
focus
larg
evalu
total
content
siga
specif
antibodi
activ
describ
previous
mammari
secret
nonlact
breast
contain
siga
although
amount
seem
much
lower
lactat
breast
mammari
secret
patient
galactorrhea
seem
contain
siga
concentr
similar
normal
postpartum
colostrum
although
malnutrit
associ
reduc
secretori
antibodi
respons
extern
secret
matern
malnutrit
seem
affect
total
siga
concentr
antimicrobialspecif
antibodi
activ
milk
contrast
note
preced
paragraph
poor
matern
nutrit
hungri
season
gambia
associ
decreas
thymu
size
nutrit
immunolog
composit
milk
mother
prematur
infant
seem
significantli
differ
milk
mother
infant
born
term
compar
studi
conduct
first
week
lactat
suggest
mean
concentr
lactoferrin
lysozym
higher
preterm
term
milk
siga
predomin
immunoglobulin
preterm
term
milk
although
siga
concentr
seem
significantli
higher
preterm
milk
collect
first
week
lactat
siga
antibodi
activ
certain
organ
e
coli
somat
antigen
preterm
milk
observ
less
best
similar
found
term
milk
addit
number
lymphocyt
macrophag
milk
seem
lower
week
significantli
higher
week
milk
mother
preterm
born
week
gestat
age
infant
milk
mother
fullterm
infant
author
investig
propos
observ
chang
may
reflect
lower
volum
milk
produc
mother
deliv
preterm
infant
possibl
remain
chang
immunolog
profil
preterm
milk
may
consequ
inadequ
stimul
preterm
infant
alter
matern
hormon
milieu
factor
underli
prematur
deliveri
develop
mucos
integr
gut
seem
depend
matur
mucos
tissu
establish
normal
gut
flora
former
repres
anatom
enzymat
blockag
invas
microorgan
antigen
latter
repres
inhibit
colon
pathogen
bacteria
although
permeabl
neonat
gut
immunoglobulin
shortliv
damag
neonat
gut
permeabl
host
protein
macromolecul
sever
week
longer
larg
milk
protein
peptid
bovin
serum
albumin
shown
enter
circul
induc
circul
antibodi
respons
inflam
ischem
gut
even
porou
antigen
pathogen
variou
proven
presum
mechan
role
siga
normal
flora
propos
compens
temporari
inadequaci
breastfeed
strongli
implic
support
gastrointestin
homeostasi
neonat
establish
normal
gut
flora
observ
shown
reduc
rate
diarrheal
diseas
breastf
infant
even
face
contamin
fed
milk
e
coli
shigella
speci
prevent
therapeut
role
breastfeed
also
suggest
nurseri
outbreak
diarrheal
diseas
caus
enteropathogen
strain
e
coli
rotaviru
breastfeed
play
inhibitori
role
appear
e
coli
agglutinin
found
fece
colon
infant
addit
divers
serotyp
aerob
gramneg
bacilli
present
oropharynx
gastrointestin
tract
neonat
may
serv
sourc
antigen
boost
presensit
mammari
gland
lead
modul
specif
bacteri
growth
mucosa
precis
role
antibodi
block
adher
pathogen
gut
effect
factor
lactoperoxidas
lactoferrin
lysozym
commens
flora
situat
uncertain
extens
epidemiolog
evid
support
prophylact
valu
breastfeed
particularli
exclus
breastfeed
first
month
life
addit
complementari
feed
thereaft
prevent
amelior
diarrheal
diseas
infant
young
children
develop
develop
nation
summar
sever
review
ampl
experiment
anim
data
valu
specif
colostr
antibodi
prevent
diarrheal
ill
avail
studi
colostr
depriv
includ
colibacteriosi
associ
e
coli
swine
rotavir
gastroenter
cattl
swine
sheep
diarrheal
ill
associ
transmiss
gastroenter
swine
human
cholera
rare
infanc
especi
endem
area
preval
breastfeed
high
experi
outbreak
cholera
persian
gulf
lend
support
possibl
absenc
breastfeed
import
variabl
increas
risk
cholera
infanc
report
claim
nurseri
outbreak
diarrhea
associ
enteropathogen
strain
e
coli
interrupt
use
breast
milk
conflict
data
exist
regard
prevent
human
rotavir
infect
diseas
evalu
nurseri
outbreak
rotavir
diseas
suggest
incid
infect
ill
lower
breastf
infant
incid
symptom
formulaf
infant
also
low
studi
done
japan
note
fivefold
decreas
incid
rotavir
infect
among
breastf
infant
younger
month
rotaviru
infect
neonat
asymptomat
regardless
breastfeed
bottlefeed
basi
care
clinic
observ
bishop
cowork
australia
first
question
posit
effect
breastfeed
rotaviru
infect
recent
casecontrol
studi
enter
viral
infect
breastf
infant
suggest
breastfeed
may
protect
infant
hospit
rather
infect
longitudin
followup
larg
cohort
infant
commun
outbreak
rotaviru
shown
attack
rate
rotaviru
infect
similar
breastf
bottlef
infant
frequenc
clinic
diseas
diarrhea
seem
significantli
lower
breastf
infant
howev
protect
observ
patient
reflect
alter
microbi
flora
breastfeed
specif
immunolog
protect
rotaviru
breast
milk
contain
siga
direct
rotaviru
greatest
concentr
colostrum
lower
amount
matur
milk
neutral
rotaviru
breast
milk
correl
imperfectli
antibodi
concentr
measur
enzym
immunoassay
suggest
factor
present
milk
contribut
rotaviru
neutral
seem
breastfeed
provid
signific
protect
diarrheal
diseas
although
mechan
protect
remain
fulli
defin
necrot
enterocol
complex
ill
stress
prematur
infant
often
associ
hypoxia
gut
mucos
ischemia
necrolysi
death
clinic
manifest
occasion
associ
bacteremia
invas
gramneg
bacilli
particularli
klebsiella
pneumonia
intestin
submucosa
clinic
manifest
includ
abdomin
distent
gastric
retent
bloodi
diarrhea
classic
radiograph
find
includ
air
bowel
wall
pneumatosi
intestinali
air
portal
system
free
infradiaphragmat
air
signifi
perfor
treatment
involv
decompress
system
antibiot
often
surgeri
numer
studi
suggest
benefici
role
breast
milk
prevent
modifi
develop
necrot
enterocol
highrisk
human
infant
pediatr
center
claim
virtual
absenc
necrot
enterocol
breastf
infant
howev
mani
instanc
failur
milk
feed
prevent
human
necrot
enterocol
also
report
outbreak
necrot
enterocol
relat
klebsiella
salmonella
speci
secondari
bank
human
milk
feed
document
asphyxi
neonat
rat
model
necrot
enterocol
entir
syndrom
could
prevent
feed
matern
milk
crucial
factor
milk
seem
cell
probabl
macrophag
also
possibl
antibodi
nonspecif
factor
play
role
establish
gut
flora
prophylact
oral
administr
immunoglobulin
found
profound
influenc
outcom
necrot
enterocol
wellcontrol
studi
penetr
gut
pathogen
antigen
increas
ischem
damag
noncellular
element
milk
may
aid
blockag
transit
necrot
enterocol
complex
diseas
entiti
whose
pathogenesi
caus
remain
defin
although
breastfeed
may
protect
mani
factor
relat
mechan
mucos
injuri
pathogenesi
syndrom
incid
bacteremia
among
prematur
infant
fed
breast
milk
suggest
significantli
lower
among
prematur
infant
receiv
formula
feed
feed
decreas
incid
neonat
sepsi
includ
sepsi
associ
gramneg
bacilli
e
coli
serotyp
also
link
breastfeed
antibodi
compartment
cellular
reactiv
serotyp
shown
human
colostrum
studi
fail
howev
show
clear
evid
protect
system
infect
breastf
infant
review
evid
protect
low
birth
weight
neonat
lateonset
sepsi
use
human
milk
suggest
qualiti
current
evid
insuffici
show
benefici
effect
although
author
reach
differ
conclus
one
challeng
develop
human
milk
research
demonstr
breastf
infant
reduc
incid
diseas
autoregul
dysregul
immun
long
termin
breastfeed
sinc
first
report
numer
publish
studi
address
effect
infant
feed
develop
atop
diseas
asthma
benefici
result
breastfeed
prophylaxi
atopi
observ
studi
howev
other
benefici
effect
report
infant
genet
determin
risk
atop
diseas
final
benefici
effect
even
increas
risk
suggest
breastf
infant
kramer
extens
metaanalysi
studi
publish
focus
infant
feed
atop
diseas
attempt
shed
light
controversi
studi
asthma
includ
analysi
claim
protect
effect
breastfeed
wherea
claim
protect
sever
seriou
methodolog
drawback
note
analysi
howev
mani
studi
analyz
earli
infant
feed
histori
obtain
month
year
feed
period
ascertain
infant
feed
histori
obtain
interview
awar
diseas
outcom
insuffici
durat
exclus
breastfeed
document
confound
variabl
consid
inappropri
exposur
standard
nonblind
ascertain
diseas
outcom
found
common
violat
outcom
standard
kramer
analysi
also
found
failur
control
confound
variabl
common
violat
statist
analysi
standard
identifi
sever
studi
effect
infant
feed
subsequ
asthma
may
confound
variabl
associ
infant
feed
uniqu
investig
condit
factor
seem
greatest
potenti
confound
effect
includ
famili
histori
atop
diseas
socioeconom
statu
parent
cigarett
smoke
studi
asthma
includ
metaanalysi
adequ
control
confound
factor
three
studi
show
protect
effect
breastfeed
asthma
inadequ
statist
power
effect
infant
feed
sever
outcom
age
onset
diseas
virtual
ignor
studi
although
extens
metaanalysi
may
suggest
uncertainti
prophylact
benefit
breastfeed
studi
strongli
support
posit
effect
breastfeed
develop
atop
diseas
asthma
first
studi
consist
prospect
longterm
evalu
infanc
age
year
preval
atopi
significantli
higher
infant
shortdur
month
breastfeed
increas
demonstr
differ
age
year
infant
intermediatedur
month
prolong
month
breastfeed
differ
preval
atopi
persist
group
divid
accord
posit
neg
atop
hered
atopi
manifest
differ
infant
feed
group
remain
constant
age
particular
respiratori
allergi
includ
asthma
increas
greatli
preval
age
year
preval
group
shortdur
breastfeed
second
studi
prospect
longitudin
studi
preval
risk
factor
acut
chronic
respiratori
ill
childhood
investig
examin
relationship
infant
feed
recurr
wheez
age
year
associ
lower
respiratori
tract
ill
wheez
earli
life
children
never
breastf
significantli
higher
rate
recurr
wheez
year
age
increas
durat
breastfeed
beyond
month
associ
significantli
lower
rate
recurr
wheez
effect
breastfeed
appar
children
without
wheez
lower
respiratori
tract
ill
first
month
life
contrast
find
first
studi
howev
effect
breastfeed
signific
among
nonatop
children
exact
mechan
breastfeed
seem
confer
longlast
protect
allerg
sensit
poorli
understood
like
howev
multipl
synergist
mechan
may
respons
effect
includ
matur
recipi
gastrointestin
airway
mucosa
promot
growth
factor
present
human
milk
inhibit
antigen
absorpt
milk
siga
reduc
incid
mucos
infect
consequ
sensit
bystand
antigen
chang
microbi
flora
intestin
breastf
infant
direct
immunomodulatori
activ
human
milk
compon
recipi
infant
numer
earlier
recent
studi
greatli
contribut
understand
macromolecular
transport
across
immatur
gut
consequ
term
gener
circul
antibodi
immun
complex
process
block
predominantli
siga
glycocalyx
intestin
enzym
mucos
immunolog
event
basi
concept
immun
exclus
immun
exclus
absolut
howev
uptak
antigen
across
gut
may
enhanc
rather
block
interact
antibodi
mucos
surfac
begin
observ
igadefici
patient
becom
clear
absenc
iga
barrier
gut
associ
increas
incid
circul
antibodi
direct
mani
food
antigen
increas
occurr
atopicallerg
diseas
studi
note
complement
activ
serum
feed
bovin
milk
children
cow
milk
allergi
neonat
similar
respect
igadefici
patient
increas
transintestin
uptak
food
antigen
consequ
circul
antibodi
format
prematur
infant
report
studi
suggest
earli
breastfeed
even
short
durat
associ
decreas
serum
antibodi
respons
cow
milk
protein
prolong
breastfeed
may
partial
exclud
foreign
antigen
immun
exclus
may
also
mother
milk
infant
sole
food
prevent
ingest
intact
bovin
milk
protein
food
antigen
antibodi
observ
howev
sampl
colostrum
milk
epidemiolog
evid
suggest
bacteri
viral
respiratori
infect
less
frequent
less
sever
among
breastf
infant
variou
cultur
socioeconom
set
antibodi
immunolog
reactiv
direct
herp
simplex
viru
respiratori
syncyti
viru
infecti
agent
protect
enteroviru
infect
quantit
colostrum
milk
adopt
experi
suckl
ferret
shown
protect
young
respiratori
syncyti
viru
transfer
colostrum
contain
specif
antibodi
neonat
ferret
gut
quit
permeabl
howev
macromolecul
permit
passag
larg
quantiti
virusspecif
igg
absenc
either
document
antibodi
cellular
transfer
human
neonat
across
mucosa
mechan
protect
respiratori
syncyti
viru
respiratori
pathogen
remain
obscur
data
lack
human
regard
passiv
protect
mucos
surfac
eye
ear
genitourinari
tract
epidemiolog
evid
suggest
recurr
otiti
media
effus
strongli
associ
earli
bottlefeed
breastfeed
may
confer
protect
otiti
media
effus
first
year
life
foster
feedingacquir
antibodi
herp
simplex
viru
found
result
signific
protect
reinfect
challeng
experiment
anim
studi
numer
benefit
associ
breastfeed
includ
natur
contracept
activ
nurs
protect
sudden
infant
death
syndrom
diabet
obes
high
cholesterol
level
ischem
heart
diseas
later
life
particular
recent
interest
associ
breastfeed
improv
intellectu
perform
older
children
sever
studi
shown
enhanc
cognit
outcom
breastf
children
although
controversi
exist
regard
mechan
improv
perform
may
occur
health
benefit
mother
also
may
associ
breastfeed
reduc
incid
breast
cancer
note
women
lactat
human
milk
optim
form
nutrit
healthi
term
infant
almost
situat
failur
initi
lactat
properli
earli
breastfeed
may
present
risk
dehydr
infant
insuffici
fluid
may
ingest
inappropri
introduct
bottl
pacifi
also
may
interfer
proper
induct
lactat
later
lactat
introduct
bottl
may
induc
prematur
wean
result
reduct
milk
suppli
circumst
identifi
breastfeed
contraind
other
identifi
continu
breastfeed
conduct
caution
protect
infant
infant
inherit
metabol
diseas
may
requir
altern
form
nutrit
neonat
classic
galactosemia
owe
defici
uridyltransferas
receiv
lactosefre
milk
lactos
glucosegalactos
disaccharid
infant
phenylketonuria
may
receiv
human
milk
support
requir
phenylalanin
often
may
better
manag
use
special
prepar
commerci
milk
mother
receiv
radionuclid
diagnost
therapeut
purpos
use
altern
form
nutrit
day
week
requir
compound
elimin
mother
receiv
certain
chemotherapeut
immunosuppress
agent
activ
use
drug
abus
includ
amphetamin
cocain
heroin
phencyclidin
lowlevel
matern
exposur
environment
chemic
tobacco
smoke
avoid
much
possibl
contraind
breastfeed
antimicrobi
agent
taken
mother
rare
repres
contraind
breastfeed
first
principl
antimicrobi
may
safe
given
infant
may
safe
given
lactat
mother
blood
concentr
may
achiev
breast
milk
ingest
lower
therapeut
dose
use
infant
breastfeed
mother
receiv
chloramphenicol
contraind
use
may
associ
fatal
complic
newborn
infant
effect
metronidazol
uncertain
minim
exposur
drug
mutagen
bacteria
mother
receiv
singledos
therapi
discontinu
breastfeed
hour
excret
antibiot
human
milk
also
discuss
chapter
uptod
inform
regard
drug
lactat
reader
consult
http
wwwtoxnetnlmnihgovcgibinsishtmlgen
lact
sever
instanc
specif
nutrient
defici
breastf
infant
describ
specif
relat
lack
vitamin
k
vitamin
vitamin
b
folic
acid
vitamin
c
carnitin
instanc
sever
case
report
appear
warn
defici
result
clinic
consequ
neonat
hemorrhag
diseas
report
breastf
infant
success
treat
vitamin
k
infant
receiv
vitamin
k
birth
mother
practic
unusu
dietari
habit
strict
vegetarian
may
reduc
level
vitamin
b
folic
acid
milk
defici
breastf
infant
mother
report
case
ricket
breastf
infant
report
particularli
winter
among
infant
expos
sun
defici
carnitin
nutrient
respons
modul
fat
absorpt
also
report
result
clinic
symptom
breastf
infant
mother
ingest
unusu
diet
concern
best
address
almost
case
counsel
mother
regard
nutrit
practic
provis
supplement
vitamin
micronutri
appropri
case
develop
world
even
develop
world
untoward
consequ
breastfeed
particularli
great
manag
hyperbilirubinemia
associ
breastfeed
area
controversi
present
recommend
continu
breastfeed
effort
increas
volum
milk
ingest
provis
sever
hyperbilirubinemia
brief
interrupt
breastfeed
might
appropri
human
milk
may
contain
infecti
agent
secret
milk
enter
milk
lactat
acquir
milk
improperli
collect
store
later
fed
infant
formal
train
evalu
breastfeed
practic
train
caregiv
best
way
reduc
risk
routin
cultur
heat
treatment
mother
milk
even
store
later
use
feed
infant
costeffect
store
milk
commonli
use
feed
infant
mother
unabl
breastfe
directli
work
travel
constraint
infant
prematur
otherwis
unabl
breastfe
effect
inadvert
feed
store
milk
birth
mother
occur
nurseri
occur
aap
recommend
handl
manner
accident
exposur
blood
bodi
fluid
occur
see
chapter
addit
inform
unit
state
human
milk
bank
associ
north
america
http
wwwhmbanaorg
collect
human
donor
milk
purpos
administr
infant
whose
mother
milk
unavail
inadequ
member
associ
follow
guidelin
formul
consult
us
food
drug
administr
fda
center
diseas
control
prevent
guidelin
help
ensur
donor
screen
transmiss
infect
milk
care
collect
process
store
use
practic
donor
milk
collect
pool
subject
holder
pasteur
c
minut
reliabl
kill
bacteria
inactiv
hiv
cytomegaloviru
cmv
elimin
substanti
reduc
amount
virus
pool
milk
test
ensur
meet
standard
frozen
later
distribut
use
transmiss
bacteri
pathogen
includ
aureu
group
b
streptococci
mycobacteria
speci
may
occur
breastfeed
tabl
mastiti
breast
abscess
may
associ
substanti
concentr
bacteria
mother
milk
gener
feed
infant
breast
affect
abscess
recommend
infant
feed
affect
breast
may
resum
howev
hour
drainag
initi
appropri
antibiot
therapi
mastiti
usual
resolv
appropri
antimicrobi
therapi
continu
lactat
even
feed
affect
breast
temporarili
interrupt
condit
feed
unaffect
breast
need
interrupt
mother
activ
tuberculosi
refrain
breastfeed
least
week
longer
institut
appropri
treatment
consid
contagi
recommend
also
appli
uncommon
situat
mastiti
breast
abscess
caus
mycobacterium
tuberculosi
virus
detect
human
milk
includ
cmv
hepat
b
hbv
hepat
c
hcv
virus
herp
simplex
viru
human
tlymphotrop
viru
rubella
viru
west
nile
viru
see
tabl
unknown
whether
varicella
viru
secret
human
milk
although
virus
present
risk
infant
benefit
breastfeed
infant
greater
risk
cmv
infect
common
perinat
infect
viru
shed
milk
infect
mother
although
breastfeed
infect
mother
may
result
seroconvers
breastfeed
neonat
infect
often
associ
clinic
symptom
diseas
infant
low
birth
weight
g
may
exhibit
evid
clinic
diseas
howev
thrombocytopenia
neutropenia
hepatosplenomegali
seen
low
birth
weight
infant
infect
breastfeed
decis
breastfe
prematur
infant
infect
mother
base
weigh
potenti
benefit
human
milk
versu
risk
cmv
transmiss
hepat
b
surfac
antigen
detect
milk
hbvinfect
mother
nevertheless
breastfeed
increas
risk
hbv
infect
among
infant
infant
born
hbvposit
mother
receiv
hepat
b
immunoglobulin
recommend
seri
hepat
b
vaccin
without
delay
institut
breastfeed
rna
hcv
antibodi
hcv
detect
milk
infect
mother
transmiss
via
breastfeed
document
antihcvposit
antihivneg
mother
theoret
possibl
mother
inform
decid
whether
breastfe
accord
current
guidelin
hcv
infect
contraind
breastfeed
herp
simplex
viru
transmiss
directli
matern
breast
lesion
infant
shown
women
lesion
one
breast
may
feed
unaffect
breast
make
sure
lesion
breast
part
bodi
cover
use
care
hand
hygien
numer
studi
shown
hiv
milk
find
includ
isol
hiv
milk
supernat
collect
symptomfre
women
cellular
fraction
matern
milk
recoveri
hiv
virion
histiocyt
cellfre
extract
milk
electron
microscopi
detect
viral
dna
polymeras
chain
reaction
greater
sampl
hivseroposit
lactat
women
transmiss
hiv
breastfeed
may
account
one
third
one
half
hiv
infect
global
risk
transmiss
approxim
breastfeed
continu
beyond
first
year
life
risk
postnat
hiv
transmiss
seem
constant
throughout
first
month
life
risk
cumul
durat
breastfeed
increas
risk
transmiss
via
breast
milk
greater
matern
hiv
infect
acquir
lactat
viral
load
greater
matern
diseas
advanc
infant
breastf
formulaf
mother
bleed
crack
nippl
mastiti
breast
abscess
infant
thrush
certain
coinfect
see
chapter
detail
current
recommend
aap
author
state
popul
unit
state
risk
death
infecti
diseas
malnutrit
low
safe
effect
altern
sourc
feed
readili
avail
hivinfect
women
counsel
breastfe
infant
donat
milk
one
report
found
highli
activ
antiretrovir
therapi
administ
pregnanc
postpartum
suppress
hiv
rna
dna
breast
milk
present
aap
recommend
infant
hivinfect
mother
unit
state
receiv
highli
activ
antiretrovir
therapi
breastf
despit
potenti
risk
hiv
infect
infant
hivinfect
breastfeed
mother
consider
cessat
breastfeed
must
balanc
benefici
effect
describ
chapter
area
world
infecti
diseas
malnutrit
import
caus
death
earli
life
benefici
effect
breastfeed
often
outweigh
potenti
risk
hiv
transmiss
breastfeed
studi
set
shown
hivfre
surviv
month
age
similar
expos
infant
breastf
formulaf
birth
studi
africa
show
mother
exclus
breastfe
first
month
life
reduc
risk
hiv
transmiss
compar
mother
supplement
breastfeed
food
milk
sourc
area
world
burden
infecti
diseas
malnutrit
high
altern
breast
milk
provid
adequ
nutrit
unaccept
afford
feasibl
safe
exclus
breastfeed
recommend
author
women
whose
hiv
statu
unknown
women
known
hivinfect
polici
also
stress
need
continu
support
breastfeed
mother
hivneg
improv
access
hiv
counsel
test
govern
effort
ensur
uninterrupt
access
nutrit
adequ
human
milk
substitut
human
tlymphotrop
virus
endem
japan
caribbean
part
south
america
infect
transmit
mother
infant
transmiss
occur
primarili
breastfeed
infect
identifi
nativ
american
nativ
alaskan
inject
drug
abus
unit
state
europ
mothertoinf
transmiss
shown
although
frequenc
occur
rout
transmiss
uncertain
women
unit
state
known
seroposit
breastfe
routin
screen
recommend
rubella
viru
recov
milk
natur
vaccineassoci
infect
associ
signific
diseas
infant
although
transient
seroconvers
frequent
shown
contraind
breastfeed
exist
women
recent
immun
current
licens
rubella
vaccin
rna
west
nile
viru
detect
human
milk
seroconvers
breastfeed
infant
also
observ
although
west
nile
viru
transmit
milk
extent
transmiss
human
remain
determin
infant
children
infect
viru
date
asymptomat
minim
diseas
risk
uncertain
aap
recommend
women
endem
area
may
continu
breastfe
intern
nation
organ
endors
breastfeed
optim
mean
feed
healthi
term
infant
percentag
mother
initi
breastfeed
develop
countri
gener
greater
often
greater
health
econom
consequ
bottlef
infant
countri
sever
howev
unit
state
one
point
earli
rate
breastfeed
initi
rate
initi
sinc
time
increas
fluctuat
time
survey
ifp
ii
conduct
fda
respond
initi
breastfeed
contrast
favor
trend
recommend
exclus
breastfeed
first
month
life
unit
state
intern
uncommonli
follow
unit
state
supplement
feed
often
initi
hospit
immedi
postpartum
period
month
age
infant
receiv
formula
similarli
although
breastfeed
initi
approach
develop
nation
africa
asia
caribbean
rate
exclus
breastfeed
first
month
life
approxim
approxim
infant
less
month
month
age
within
unit
state
variou
demograph
pattern
seem
associ
breastfeed
behavior
older
mother
mother
colleg
educ
mother
higher
incom
like
breastfe
african
american
hispan
mother
mother
lower
socioeconom
statu
particip
women
infant
children
wic
program
us
depart
health
human
servic
mother
live
southern
region
unit
state
much
less
like
breastfe
low
rate
breastfeed
mother
enrol
wic
particular
concern
agenc
specif
polici
encourag
breastfeed
mani
state
depend
formula
manufactur
rebat
fund
part
wic
program
howev
creat
conflict
interest
disturb
part
demograph
pattern
breastfeed
unit
state
infant
lower
socioeconom
statu
mother
would
accru
greatest
health
econom
benefit
breastfeed
least
like
breastf
although
demograph
studi
indic
breastfeed
explain
behavior
differ
among
group
mother
one
complet
model
design
explain
breastfeed
behavior
includ
compon
address
matern
attitud
famili
societ
cultur
environment
variabl
individu
studi
shown
matern
decisionmak
process
close
relat
social
support
influenc
come
famili
member
surround
mother
husband
particular
seem
strong
posit
influenc
wherea
mother
mother
may
neg
influenc
breastfeed
decis
social
support
seem
differ
among
ethnic
group
matern
attitud
differ
may
provid
one
explan
differ
breastfeed
behavior
among
ethnic
group
higher
rate
exclus
breastfeed
observ
infant
born
us
hospit
follow
practic
recommend
whounit
nation
children
fund
babyfriendli
hospit
initi
emphas
step
promot
success
breastfeed
human
milk
contain
wide
varieti
solubl
cellular
compon
divers
spectrum
biolog
function
major
milk
compon
identifi
date
exhibit
antimicrobi
antiinflammatori
proinflammatori
immunoregulatori
function
cytotox
tumor
cell
abil
repair
tissu
damag
receptor
analogu
function
metabol
effect
biolog
activ
differ
milk
compon
summar
tabl
polymorphonuclear
leukocyt
macrophag
lymphocyt
epitheli
cell
observ
human
milk
function
milk
unknown
possibl
primari
task
antimicrobi
defens
mammari
gland
cell
may
help
promot
toler
mother
hla
allotyp
may
implic
regard
immun
respons
allograft
reject
bulk
antimicrobi
effect
human
milk
associ
milk
immunoglobulin
especi
siga
isotyp
make
immunoglobulin
human
bodi
milk
antibodi
seem
provid
protect
mani
intestin
pathogen
campylobact
shigella
e
coli
v
cholera
giardia
rotaviru
respiratori
pathogen
respiratori
syncyti
viru
milk
antibodi
also
effect
neutral
toxin
variou
human
virus
role
small
amount
igg
igm
milk
uncertain
milk
iga
antibodi
gener
induc
antimicrobi
protect
absenc
inflamm
lactoferrin
lysozym
alactalbumin
milk
protein
carbohydr
lipid
also
contribut
antimicrobi
immunomodulatori
properti
human
milk
milk
also
contain
numer
cytokin
chemokin
growth
factor
solubl
tlr
modul
inflammatori
immunolog
respons
gut
passiv
transfer
divers
matern
biolog
experi
neonat
process
breastfeed
repres
essenti
compon
surviv
mechan
mammalian
neonat
million
year
matern
product
lactat
deliv
process
breastfeed
sole
sourc
nutrit
immun
neonat
period
earli
infanc
mammal
includ
human
infant
past
year
human
societi
undergon
remark
chang
major
impact
basic
mechan
maternalneonat
interact
breastfeed
environ
chang
includ
introduct
sanit
nonhuman
milk
formula
feed
neonat
nutrit
use
antimicrobi
agent
introduct
process
food
exposur
newer
environment
macromolecul
dietari
antigen
introduct
humanmad
chang
neonat
environ
profound
impact
human
homeostat
mechan
allow
new
insight
role
breastfeed
develop
human
neonat
compar
analysi
natur
tradit
form
breastfeed
artifici
feed
modal
shown
natur
breastfeed
associ
signific
reduct
infant
mortal
morbid
protect
acut
infecti
diseas
possibl
protect
allerg
disord
autoimmun
diseas
acut
chronic
inflammatori
disord
obes
diabet
mellitu
metabol
disord
allograft
reject
develop
mani
malign
condit
childhood
later
life
inform
review
hanson
eleg
monograph
other
despit
overwhelmingli
protect
role
attribut
natur
breastfeed
evolutionari
advantag
relat
develop
lactat
sever
infecti
agent
acquir
cours
evolut
abil
evad
immunolog
factor
milk
use
milk
vehicl
maternaltoinf
transmiss
potenti
acquisit
infect
includ
hiv
htlv
cmv
possibl
pathogen
highlight
potenti
hazard
breastfeed
clinic
situat
reason
conclud
develop
lactat
hallmark
mammalian
evolut
design
enhanc
surviv
neonat
speci
breastfeed
may
remark
spectrum
immedi
longterm
protect
function
